Kyrgyzstan ranks among the 30 global high-burden countries for multidrug-resistant TB (MDR-TB) and 18 priority countries for TB in the World Health Organization (WHO) European Region, with an estimated incidence of MDR-TB of 26 percent among new cases and 55 percent among previously treated cases. The USAID Cure Tuberculosis project, led by JSI in partnership with University Research Co., LLC, provided technical assistance to the NTP, which included optimization of the lab system, expansion of the sputum transportation system, implementation of a quality management system in labs, introduction of innovative new diagnostic methods, and upgrading the Laboratory Data Management Information System.
We strive to build lasting relationships to produce better health outcomes for all.
